🟢 Ardelyx is trading 12% up in after-hours trading after Q3 report shows 23% IBSRELA growth

Ardelyx is trading at $3.40, up 12.21%, after reporting third-quarter results on November 3.

• The company reported a net loss of $0.7 million, or approximately break-even per share. IBSRELA product revenue grew 23% year over year to $96.3 million.
• Total product revenue was $125.5 million, below the $128.7 million consensus. Ardelyx reiterated 2026 IBSRELA revenue guidance of $350 million to $370 million. Shares closed at $3.03 and moved to $3.40 after hours; the release followed the regular session.